Phelan-McDermid Syndrome (PMS) is a rare genetic syndrome in which one copy of the q13 portion of chromosome 22 is missing. The neurological and psychiatric phenotypes are due to loss of the SHANK3 gene contained in this region of the genome. Mutations in the SHANK3 gene also produce a syndrome with the neurological and behavioral aspects of PMS.

News & Events

Keep up with the latest news

Mount Sinai a Lead Site in NIH-Funded Rare Diseases Consortium Studying Autism and Intellectual Disability

10-institution study seeks to pilot new treatment approaches NEW YORK, NY – October 15, 2014 /Press Release/  ––  Under a five-year, $6 million grant from the National Institutes of Health’s (NIH) Rare Disease Clinical Research Network, the Icahn School of Medicine at Mount Sinai (ISMMS) will serve as one of 10 medical centers that have formed the Developmental [...]

Find out more

Testing & Evaluation

Families coping with a diagnosis of Phelan-McDermid Syndrome, 22q13 Deletion Syndrome, or a SHANK3 mutation or who are looking to learn more about the condition have resources available to them.

Find out more

The Seaver Autism Center at the Icahn School of Medicine at Mount Sinai

The Seaver Autism Center offers comprehensive assessment and care for people with developmental delay, including autism spectrum conditions and associated disorders. The Center works with families affected with Phelan-McDermid Syndrome, 22q13 Deletion Syndrome, and SHANK3 mutations.

Find out more